glp-1 patient medications and weight loss: Helping patients navigate beyond the trends Why GLP-1 Medications Are Suddenly

It is incredibly important as a healthcare system that we start treating obesity as a long-term condition and wrap care around people living with obesity, which may include diet, lifestyle, psychological support and, for some people, medication to help them manage and lower their weight. 1.Wharton S, Freitas P, Hjelmesth J, et al

A post hoc analysis of the phase IIb trial showed that tirzepatide was associated with a reduction in the level of high-sensitivity ICAM-1, CRP, and YKL-40 after 26 weeks of treatment in a dose-dependent manner [83, 103]

In an initial pilot study, we demonstrated the need for more comprehensive validation [2]

Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial